glp 1 conference 2025 2nd GLP-1-Based Therapeutics Summit [04/29/25] GLP-1 Summit 2025

Learn about the new Medicare Bridge program, state Medicaid rules, and how to appeal a denial.

Learn why it happens and how to protect your strength and lean mass while on GLP-1 meds.

All-Natural Herbal Blend: Crafted with Raw Apple Cider Vinegar and Wildflower Honey100% pure ingredients, gluten-free, alcohol-free, and non-GMO

Enhance your wellness journey with these easy-to-use packets that seamlessly fit into your diet

GLP-1R agonist 2 (compound 2) is an effective GLP-1R agonist that exerts its activating effect by forming hydrogen bonds with the Tyr42, Cys71, and Ser84 residues of GLP-1R

Currently, there are ten classes of orally available pharmacological agents to treat T2DM: 1) sulfonylureas, 2) meglitinides, 3) metformin (a biguanide), 4) thiazolidinediones (TZDs), 5) alpha glucosidase inhibitors, 6) dipeptidyl peptidase IV (DPP-4) inhibitors, 7) bile acid sequestrants, 8) dopamine agonists, 9) sodium-glucose transport protein 2 (SGLT2) inhibitors and 10) oral glucagon like peptide 1 (GLP-1) receptor agonists